Jeha S, Cheng C, et al. 2. Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Res ponse-Adapted Therapy. Leukemia. 2017;31(2):333–9. Impact of Routine Cytological CSF Analysis at the Time of Intrathecal Chemotherapy. Pediatr Blood Cancer. 2014;61:2215–2217. 48. Gajjar A, Harrison PL, Sandlund JT, Rivera GK, Ribeiro RC, Rubnitz JE, et al. 19. Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood. 2000;96(10):3381–4. 39. Bhojwani D, Pei D, Sandlund JT, Jeha S, Onciu M, Cheng C, et al. 8. ETV6-RUNX1-positive childhood acute lymphoblastic leukemia:
improved outco me with contemporary therapy Deepa. Leukemia. 2012;26(2):265–70. 49. Bьrger B, Zimmermann M, Mann G, Kьhl J, Lцning L, Riehm H, et al. 20. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: Significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21(2):184–8. 40. Pui CH, Pei D, Campana D, Bowman WP, Sand lund JT, Kaste SC, et al. 14. Improved prognosis for ol der adolescents with acute lymphoblastic leukemia. J Clin Oncol. 2011;29(4):386–91. 41. Gajjar A, Ribeiro RC, Mahmoud HH, Sandlund JT, Liu Q, Furman WL, et al. 18.
Overt testicular disease at diagnosis is associated with high risk features and a poor prognosis in patients with childhood acute lym phoblastic leukemia. Cancer. 1996;78(11):2437–42. 50. Sirvent N, Suciu S, Rialland X, Millot F, Benoit Y, Plantaz D, et al. 22. Prognostic significance of the ini tial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated wi thout cranial irradiation: Results of European organi zation for research and treatment of cancer (EORTC) child. Eur J Cancer. 2011;47(2):239–47. 42. Cooper SL, Brown PA. Treatment of pediatric acu te lymphoblastic leukemia. Pediatr Clin North Am. 2015;62(1):61–73. 51.
Pui C, Robinson LL, Look AT. Acute lymphoblastic leukaemia. Methods Mol Biol. 2008;371:1030–43. 43. Hijiya N, Liu W, Sandlund IT, Jeha S, Razzouk BI, Ribeiro RC, et al. 16. Overt testicular disease at diagno sis of childhood acute lymphoblastic leukemia: Lack of the therapeutic role of local irradiation. Leukemia. 2005;19(8):1399–403. 52. Asselin BL, Devidas M, Wang C, Pullen J, Borowitz MJ, Hutchison R, et al. 27. Effectiveness of high-dose methotrexate in T-cell lymphoblastic leukemia and advanced-stage lymphoblastic lymphoma: A rando mized study by the Children’s Oncology Group (POG 9404). Blood. 2011;118(4):874–83. 44.
Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M, et al. Improved early event-free survival with imatinib in Philadelphia chromosome - Positive acute lymphoblastic leukemia: A Children’s Oncology Group Study. J Clin Oncol. 2009;27(31):5175– 81. 53. Mikkelsen TS, Sparreboom A, Cheng C, Zhou Y, Bo yett JM, Raimondi SC, et al. 28. Shortening infusion time for high-dose methotrexate alters antileukemic effects: A randomized prospective: Clinical trial. J Clin Oncol. 2011;29(13):1771–8. 45. Hasegawa D, Manabe A, Ohara A, Kikuchi A, Koh K, Kiyokawa N, et al. 24.
The Utility of Performing the Initial Lumbar Puncture on Day 8 in Remission In duction Therapy for Childhood Acute Lymphoblastic Leukemia: TCCSG L99-15 Study. Pediatr Blood Cancer. 2012;58:23–30. 54. Drost SA. 29. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Recei ving High-Dose Methotrexate. Pharmacotherapy. 2017;37(6):684–91. 46. Wang B, Relling M V., Storm MC, Woo MH, Ribeiro R, Pui CH, et al. 12. Evaluation of immunologic cross reaction of antiasparaginase antibodies in acute lym phoblastic leukemia (ALL) and lymphoma patients. Leukemia. 2003;17(8):1583–8. 55. Skдrby T, Jцnsson P, Hjorth L, Behrentz M, Bjцrk O, Forestier E, et al. 30.
High-dose methotrexate: On the relationship of methotrexate elimination time vs renal function and serum methotrexate levels in 1164 courses in 264 Swedish children with acute lympho blastic leukaemia (ALL). Cancer Chemother Pharma col. 2003;51(4):311–20. 47. Gassas A, Krueger J, Alvi S, Sung L, Hitzler J, Lie berman L. 23. Diagnosis of Central Nervous System Relapse of Pediatric Acute Lymphoblastic Leukemia: GUHA DE MANEJO PARA EL DIAGNYSTICO, TRATAMIENTO Y SEGUIMIENTO DE LA LEUCEMIA LINFOBLБSTICA AGUDA PEDIБTRICA, ADAPTADA A LA CIUDAD DE SANTIAGO DE CALI – COLOMBIA 86